Question 1

Has Todd Fehniger, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $6,929 in general payments to Todd Fehniger, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Todd Fehniger, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Todd Fehniger, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Bristol Myers Squibb	4	$5,554
Takeda Pharmaceuticals U.S.A., Inc.	1	$1,375

Drug	Claims	Cost to plans & patients
BrukinsaZanubrutinib	24	$338,288
CalquenceAcalabrutinib Maleate	22	$275,059
Fluconazole	19	$1,071
Acyclovir	38	$559
Ciprofloxacin Hcl	16	$112
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	32	$92

Todd Fehniger, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other medical oncology in Saint Louis